Last update 28 Sep 2024
Metabolically Armed CD19 CAR-T cells(Leman Biotech )
Last update 28 Sep 2024
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms META10-19 |
Target |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Related
5
Clinical Trials associated with Metabolically Armed CD19 CAR-T cells(Leman Biotech )Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r DLBCL Clinical Research
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical Research
100 Clinical Results associated with Metabolically Armed CD19 CAR-T cells(Leman Biotech )
Login to view more data
100 Translational Medicine associated with Metabolically Armed CD19 CAR-T cells(Leman Biotech )
Login to view more data
100 Patents (Medical) associated with Metabolically Armed CD19 CAR-T cells(Leman Biotech )
Login to view more data
100 Deals associated with Metabolically Armed CD19 CAR-T cells(Leman Biotech )
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| CD19 Positive B-Cell Leukemia | Phase 1 | CN | 15 May 2024 | |
| CD19 positive B-Cell Lymphoma | Phase 1 | CN | 15 May 2024 | |
| Diffuse Large B-Cell Lymphoma | Phase 1 | CN | 20 Nov 2023 | |
| Diffuse Large B-Cell Lymphoma | Phase 1 | CN | 20 Nov 2023 | |
| Acute Lymphoblastic Leukemia | Phase 1 | CN | 10 Feb 2023 | |
| Non-Hodgkin Lymphoma | Phase 1 | CN | 10 Feb 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 17 | xbqfycevac(zhtqwheqzb) = hekfoteazu npckpktdnp (ibdtjvpdpq ) View more | Positive | 14 May 2024 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free